Lol!
Of course WARMTH isn't our study, that's why it's called an INDEPENDANT trial.
Of course studies can be compared. Some studies ARE comparisons of other studies (meta analyses for example).
In this case, we can't make any claims, but it is worth a PS announcement simply because of the huge difference in patient outcomes between the two studies with similar patient selection criteria. Very promising. We'll soon find out if Vision achieves a similar result to WARMTH.
- Forums
- ASX - By Stock
- Ann: New Independent Trial Data Supports Potential of Veyonda
NOX
noxopharm limited
Add to My Watchlist
2.08%
!
4.7¢

Lol!Of course WARMTH isn't our study, that's why...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.7¢ |
Change
-0.001(2.08%) |
Mkt cap ! $14.02M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.7¢ | $6.448K | 137.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 87244 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.046 |
3 | 35080 | 0.045 |
1 | 70000 | 0.044 |
1 | 50000 | 0.043 |
1 | 24390 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 87244 | 3 |
0.048 | 66514 | 1 |
0.049 | 139316 | 2 |
0.057 | 10730 | 1 |
0.061 | 16393 | 1 |
Last trade - 11.05am 10/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |